AstraZeneca plc’s : AZN:stock to follow for purchase COVID-19 vaccine may receive the FDA’s approval for emergency use in the United States, ahead of the impending presidential elections, the Financial Times reported Sunday. AstraZeneca shares slipped 1.4% to close at $55.71 on Friday.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.